Skip to main content
MTI Ltd. logo

MTI Ltd. — Investor Relations & Filings

Ticker · 9438 ISIN · JP3167480007 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 87 across all filing types
Latest filing 2025-12-19 Regulatory Filings
Country JP Japan
Listing T 9438

MTI Ltd. is a technology company that develops and distributes content and services primarily for mobile platforms. The company's operations are structured into several key business segments: Healthcare, Content, and School DX (Digital Transformation). The Healthcare division offers health management services and applications, including the 'Lunaruna' suite of apps focused on women's health. The Content business provides digital media such as music through its 'music.jp' service, comics, and other entertainment materials. In the DX segment, MTI focuses on digital solutions for the education sector. The company also develops services in areas like fintech and weather information, aiming to connect people and information through technology.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO regarding the accuracy of the Annual Securities Report (Yuuka Shouken Houkokusho). Since this is a regulatory filing required by law to accompany financial reports and does not fit into specific categories like 10-K or IR, it is classified as a general regulatory filing.
2025-12-19 Japanese
有価証券報告書-第30期(2024/10/01-2025/09/30)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a formal header identifying the document type, the fiscal period (2024-10-01 to 2025-09-30), and the company name (MTI Ltd.). The presence of XBRL-like tags and detailed financial reporting structure confirms it is the full annual report rather than an announcement or summary. FY 2025
2025-12-19 Japanese
臨時報告書
Regulatory Filings Classification · 1% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau ('関東財務局長'). The submission reason explicitly states it is based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, which mandates filing for events causing a significant impact on the company's financial condition or operating results. The content details a resolution by the Board of Directors on May 23, 2025, to sell a portion of shares in a consolidated subsidiary (Pharmow Co., Ltd.), resulting in an expected gain on the sale of affiliated company shares (900 million JPY) to be recorded as extraordinary income in the non-consolidated third quarter results. This structure—a formal filing announcing a significant, non-routine corporate event (like a major asset sale or divestiture) that impacts financials—is characteristic of a significant event disclosure required under Japanese regulations, which often falls under the general 'Regulatory Filings' category when a more specific code like M&A (TAR) or Capital Change (CAP) is not a perfect fit. Since the core event is a divestiture/sale of a subsidiary stake resulting in a one-time gain, and it is filed as an 'Extraordinary Report' (which is a general disclosure mechanism), the most appropriate general regulatory filing code is RNS, as it is a mandatory, non-periodic regulatory disclosure that doesn't fit the other specific categories like ER, IR, or 10-K.
2025-05-27 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 30
2025-05-15 Japanese
半期報告書-第30期(2024/10/01-2025/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management analysis (MD&A), and auditor review information for the interim period ending March 31, 2025. This fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-05-15 Japanese
訂正有価証券届出書(参照方式)
Share Issue/Capital Change Classification · 1% confidence The document explicitly states in the header section (【提出書類】) that it is a "有価証券届出書" (Securities Registration Statement). This type of filing in Japan is used to register securities offerings, often preceding a public offering or a third-party allotment (which is detailed extensively in the body, specifically as a "第三者割当増資" or third-party allotment increase). While the US equivalent might be an S-1 or similar registration, within the provided Japanese context and definitions, this document details a capital raising/financing activity (issuance of new shares via third-party allotment) and is a formal regulatory filing related to that issuance. The closest category that covers formal registration/prospectus-like documents for capital changes is 'Capital/Financing Update' (CAP), as it is fundamentally about raising capital. It is not a 10-K (Annual Report), IR (Interim Report), or ER (Earnings Release). Since it is a comprehensive registration document detailing the offering terms, price, use of proceeds, and allotment details, CAP is the most appropriate fit over the general 'RNS' fallback.
2025-02-19 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.